Table 1.
Characteristics | n = 26 |
---|---|
Gender | |
Male | 20 (77%) |
Female | 6 (23%) |
Age (years) | |
Median | 52 |
Range | 38–77 |
Clinical stage | |
T2 | 5 (19%) |
T3 | 16 (62%) |
T4 | 5 (19%) |
N1–2 | 23 (88%) |
Distance (cm) from anal verge | |
Median | 7 |
Low (0–5) | 10 |
Mid (> 5–10) | 11 |
High (> 10–15) | 5 |
Doses* of neoadjuvant chemotherapy | |
Median | 4 |
Range | 3–8 |
Surgery | |
Surgical resection | 20 (77%) |
Non-operative management/watch-and-wait | 6 (23%) |
*See text for definition of dose/cycle